A team led by BBRF grantees has proposed a markedly new way of understanding the role of dopamine in the brain in processes involved in learning and memory. The revised view of the neurotransmitter…
Read More
A team of researchers has reported progress in testing a new approach involving the dopamine system that they hope may help reduce symptoms of post-traumatic stress disorder (PTSD).
Read More
In the continuing effort to develop new medicines to treat schizophrenia, a team led by BBRF Scientific Council member Jeffrey Lieberman, M.D., and including nine other Council Members, BBRF grantees…
Read More
By inhibiting a previously untargeted nerve-cell receptor in the brain, researchers have discovered a new class of compounds that may be useful in the treatment of schizophrenia. In animal models of…
Read More
An area of the forebrain called the basal ganglia helps people to decide which actions to take—should I eat this apple?—and whether the action had a good (the apple was tasty) or bad (the apple was…
Read More